Quantcast
Last updated on April 19, 2014 at 13:20 EDT

Latest Entia Biosciences Inc. Stories

2013-05-15 16:27:03

Expanded GROH® line to be launched at Intercoiffure America/Canada May 19th & 20th SHERWOOD, Ore., May 15, 2013 /PRNewswire/ -- Entia Biosciences, Inc. (OTCQB: ERGO) announced today it has hired Sabrina Jetton to spearhead the Company's product innovation, communications, and branding initiatives as Director of Marketing.  Since joining the team in April, Jetton has been leading the preparations for the upcoming launch of the expanded GROH® hair care and beauty line, which...

2013-04-02 12:32:14

SHERWOOD, Ore., April 2, 2013 /PRNewswire/ -- Entia Biosciences (OTCQB: ERGO), a food science biotechnology company and emerging leader in the field of Nutrigenomics, has now received three Patent Notices of Allowance covering the use of Ergothioneine and its genetic transporter in the treatment of a wide variety of diseases, including those affecting the immune and central nervous systems. Notices from the United States Patent and Trademark Office and the Israel Patent Office were received...

2013-01-07 12:28:02

SHERWOOD, Ore., Jan. 7, 2013 /PRNewswire/ -- Entia Biosciences (OTCBB: ERGO), a food science biotechnology company and emerging leader in the field of Nutrigenomics, announced today that it has filed a PCT patent covering the use of Ergothioneine and/or Vitamin D2 to improve the growth and health of hair, skin and nails. The scientific knowledge underpinning this application claims priority to a provisional use patent filed on December 29, 2011 that addresses naturally and synthetically...

2012-12-17 12:21:16

SHERWOOD, Ore., Dec. 17, 2012 /PRNewswire/ -- Entia Biosciences (OTCBB: ERGO), a food science biotechnology company and emerging leader in the fields of Nutrigenomics and Targeted Nutrition, has received a Patent Notice of Allowance from the Canadian Intellectual Property Office covering the use of Ergothioneine and its genetic transporter (SLC22A4) in the treatment of a wide variety of diseases, including those affecting the immune and central nervous systems. Ergothioneine is a powerful...

2012-06-13 06:25:02

SHERWOOD, Ore., June 13, 2012 /PRNewswire/ -- Entia Biosciences, Inc. (OTCBB: ERGO) (ENTIA) today announced that it has received a patent from the Nation of Canada covering the "Use of Ergothioneine as a Preservative in Foods and Beverages." The new patent No. 2,680,223 expires on March 7, 2028 and has also been filed with the United States Patent Office and the European Union. The food and beverage preservation patent is the first of the Company's many patent applications to issue and was...

2012-06-06 06:25:47

SHERWOOD, Ore., June 6, 2012 /PRNewswire/ -- Entia Biosciences, Inc. (OTCBB: ERGO) (ENTIA) announced today that it has commenced an exploratory study at a nationally recognized teaching/research hospital on the West Coast to evaluate the clinical tolerability and potential therapeutic benefits of ErgoD2(TM) Hemo in patients being treated for Diabetes and Anemia. A second international site, in a region where diabetes has become epidemic in proportions, has also agreed to participate in the...